Although large datasets document that stimulants decrease the risk for many adverse ADHD-associated outcomes, compliance with stimulants remains poor.
Aims:
This study examined the effectiveness of a novel ADHD-centric text messaging-based intervention aimed to improve adherence to stimulant medications in children with ADHD.
Methods:
Subjects were 87 children aged 6–12, who were prescribed a stimulant medication for ADHD treatment. Prescribers gave permission to contact their patients for participation in the study. Subjects were primarily from the primary care setting with a subsample of psychiatrically referred subjects for comparison. Age- and sex-matched comparators were identified (3:1) from the same pool of prescriber-approved subjects that did not participate. Timely prescription refills (within 37 days) were determined from prescription dates documented in patients’ electronic medical record.
Results:
Eighty-five percent of SMS intervention patients refilled their prescriptions in a timely manner compared with 62% of patients receiving treatment as usual (OR = 3.46, 95% CI: 1.82, 6.58; p < 0.001). The number needed to treat statistic was computed as five, meaning for every five patients who receive the SMS intervention, we can keep one adherent to their stimulant treatment.
Conclusions:
These preliminary findings support the potential utility of a readily accessible technology to improve the poor rate of adherence to stimulant treatment in children with ADHD. To the best of our knowledge, this study is the first digital health intervention aimed at improving adherence to stimulant medication for children with ADHD. These results support the need for further examination of this technology through more definitive randomized clinical trials.
AdeyemoBOBiedermanJZafonteR, et al. (2014) Mild traumatic brain injury and ADHD: A systematic review of the literature and meta-analysis. J Atten Disord18: 576–584.
2.
AdlerLDNierenbergAA (2010) Review of medication adherence in children and adults with ADHD. Postgrad Med122: 184–191.
ArmstrongAWWatsonAJMakredesM, et al. (2009) Text-message reminders to improve sunscreen use: A randomized, controlled trial using electronic monitoring. Arch Dermatol145: 1230–1236.
5.
BarbaresiWJKatusicSKColliganRC, et al. (2007) Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: Does treatment with stimulant medication make a difference? Results from a population-based study. J Dev Behav Pediatr28: 274–287.
6.
BerwickDM (2009) What ‘patient-centered’ should mean: Confessions of an extremist. Health Aff (Millwood)28: w555–w565.
7.
BiedermanJ (2004) Impact of comorbidity in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry65: 3–7.
8.
BiedermanJFriedRDiSalvoM, et al. (2019a) Evidence of low adherence to stimulant medication among children and youths with ADHD: An electronic health records study. Psychiatr Serv70: 874–880.
9.
BiedermanJFriedRDiSalvoM, et al. (2019b) A novel text message intervention to improve adherence to stimulants in adults with attention deficit/hyperactivity disorder. J Clin Psychopharmacol39: 351–356.
10.
BiedermanJMickESurmanC, et al. (2006a) A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry59: 829–835.
11.
BiedermanJMonuteauxMCMickE, et al. (2006b) Young adult outcome of attention deficit hyperactivity disorder: A controlled 10-year follow-up study. Psychol Med36: 167–179.
12.
BiedermanJPettyCRFriedR, et al. (2008) Educational and occupational underattainment in adults with attention-deficit/hyperactivity disorder: A controlled study. J Clin Psychiatry69: 1217–1222.
13.
Canadian ADHD Resource Alliance (2008) Canadian ADHD Practice Guidelines. Available at: http://www.caddra.ca
14.
Centers for Disease Control and Prevention (CDC) (1994) Summary of notifiable diseases, United States 1994. MMWR Morb Mortal Wkly Rep, 43: 1–80.
15.
FaraoneSVBuitelaarJ (2010) Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eur Child Adolesc Psychiatry19: 353–364.
16.
FaraoneSVGlattSJ (2010) A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry71: 754–763.
17.
FaraoneSVBiedermanJWilensTE, et al. (2007) A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults. Psychol Med37: 1743–1752.
18.
FaraoneSVSergeantJGillbergC, et al. (2003) The worldwide prevalence of ADHD: Is it an American condition?World Psychiatry2: 104–113.
19.
GajriaKLuMSikiricaV, et al. (2014) Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review. Neuropsychiatr Dis Treat10: 1543–1569.
20.
GauSSShenHYChouMC, et al. (2006) Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures. J Child Adolesc Psychopharmacol16: 286–297.
21.
GoldmanLGenelMBezmanR, et al. (1998) Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA279: 1100–1107.
22.
JeromeLHabinskiLSegalA (2006) Attention-deficit/hyperactivity disorder (ADHD) and driving risk: A review of the literature and a methodological critique. Curr Psychiatry Rep8: 416–426.
23.
KendallTTaylorEPerezA, et al. (2008) Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: Summary of NICE guidance. BMJ337: a1239.
24.
KesslerRCAdlerLBarkleyR, et al. (2006) The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. Am J Psychiatry163: 716–723.
25.
KooijSJBejerotSBlackwellA, et al. (2010) European consensus statement on diagnosis and treatment of adult ADHD: The European network adult ADHD. BMC Psychiatry10: 67.
26.
LevineDMcCrightJDobkinL, et al. (2008) SEXINFO: A sexual health text messaging service for San Francisco youth. Am J Public Health98: 393–395.
27.
MackenzieH (2008) A trial of text messaging in Family Planning Clinics. Health Care Inform Rev Online12: 6–10.
28.
MaxJLansingAEKoeleSL, et al. (2004) Attention deficit hyperactivity disorder in children and adolescents following traumatic brain injury. Dev Neuropsychol25: 159–177.
29.
McKinlayAGraceRHorwoodJ, et al. (2009) Adolescent psychiatric symptoms following preschool childhood mild traumatic brain injury: Evidence from a birth cohort. J Head Trauma Rehabil24: 221–227.
30.
MedoriRRamos-QuirogaJACasasM, et al. (2008) A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry63: 981–989.
31.
MilohTAnnunziatoRArnonR, et al. (2009) Improved adherence and outcomes for pediatric liver transplant recipients by using text messaging. Pediatrics124: e844–e850.
32.
MoldavskyMSayalK (2013) Knowledge and attitudes about attention-deficit/hyperactivity disorder (ADHD) and its treatment: The views of children, adolescents, parents, teachers and healthcare professionals. Curr Psychiatry Rep15: 377.
33.
NissenSE (2006) ADHD drugs and cardiovascular risk. N Engl J Med354: 1445–1448.
34.
OlfsonMMarcusSCZhangHF, et al. (2007) Continuity in methylphenidate treatment of adults with attention-deficit/hyperactivity disorder. J Manag Care Pharm13: 570–577.
35.
PappadopulosEJensenPSChaitAR, et al. (2009) Medication adherence in the MTA: Saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry48: 501–510.
36.
PerwienARKratochvilCJFariesDE, et al. (2006) Atomoxetine treatment in children and adolescents with attention-deficit hyperactivity disorder: What are the long-term health-related quality-of-life outcomes?J Child Adolesc Psychopharmacol16: 713–724.
37.
RodgersACorbettTBramleyD, et al. (2005) Do u smoke after txt? Results of a randomised trial of smoking cessation using mobile phone text messaging. Tob Control14: 255–261.
38.
SafrenSADuranPYovelI, et al. (2007) Medication adherence in psychopharmacologically treated adults with ADHD. J Atten Disord10: 257–260.
39.
SafrenSAHendriksenESDesousaN, et al. (2003) Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care15: 787–793.
40.
SanchezRJCrismonMLBarnerJC, et al. (2005) Assessment of adherence measures with different stimulants among children and adolescents. Pharmacotherapy25: 909–917.
41.
SpencerAEFaraoneSVBoguckiOE, et al. (2016) Examining the association between posttraumatic stress disorder and attention-deficit/hyperactivity disorder: A systematic review and meta-analysis. J Clin Psychiatry77: 72–83.
42.
SpencerTJAdlerLAMcGoughJJ, et al. (2007) Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry61: 1380–1387.
43.
SpencerTJBrownASeidmanLJ, et al. (2013) Effect of psychostimulants on brain structure and function in ADHD: A qualitative literature review of magnetic resonance imaging-based neuroimaging studies. J Clin Psychiatry74: 902–917.
44.
StataCorp (2017) Stata Statistical Software: Release 15. College Station: StataCorp LLC.
45.
SwansonJ (2003) Compliance with stimulants for attention-deficit/hyperactivity disorder: Issues and approaches for improvement. CNS Drugs17: 117–131.
46.
SwansonJMArnoldLEMolinaBSG, et al. (2017) Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: Symptom persistence, source discrepancy, and height suppression. J Child Psychol Psychiatry58: 663–678.
VisserSNDanielsonMLBitskoRH, et al. (2014) Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011. J Am Acad Child Adolesc Psychiatry53: 34–46.e2.
49.
WilensTFaraoneSVBiedermanJ (2004) Attention-deficit/hyperactivity disorder in adults. JAMA292: 619–623.
50.
WilensTFaraoneSVBiedermanJ, et al. (2003) Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics111: 179–185.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
